Consolidated statement of cash flows
| in thousand EUR | Notes | 2024 | 2023 | |||
|---|---|---|---|---|---|---|
| Net cash flow from operating activities | ||||||
| Profit/(loss) for the period | –4 873 | –12 717 | ||||
| Income taxes (income)/expenses | 28 | 1 115 | –413 | |||
| Interest income | 9 | –127 | –323 | |||
| Interest expenses | 9 | 846 | 2 789 | |||
| Profit/(loss) for the period before interest and tax | –3 039 | –10 664 | ||||
| Depreciation, amortization and impairment | 8 | 5 933 | 4 247 | |||
| (Profit)/loss on sale of non-current assets | –140 | –94 | ||||
| Share of (profit)/loss of associates | 13 | 1 749 | 266 | |||
| Disposal of financial liabilities | –155 | – | ||||
| Changes in provisions and liabilities to employees | 188 | 1 317 | ||||
| Change in fair value of biological assets | 11 | –2 465 | 2 485 | |||
| Other non-cash items | –2 260 | –166 | ||||
| Operating cash flow before working capital changes | –189 | –2 609 | ||||
| Decrease/(increase) in trade and other receivables | –1 662 | 3 646 | ||||
| Decrease/(increase) in inventories | 2 478 | 4 449 | ||||
| Decrease/(increase) in prepaid expenses | 702 | –391 | ||||
| Increase/(decrease) in trade payables, other liabilities and provisions | –798 | –1 960 | ||||
| Income tax (paid)/received | –1 084 | –468 | ||||
| Net cash flow operating activities | –553 | 2 665 | ||||
| in thousand EUR | Notes | 2024 | 2023 | |||
|---|---|---|---|---|---|---|
| Cash flow from investing activities | ||||||
| Purchase of intangible assets | 12 | –50 | –153 | |||
| Proceeds from sale of property, plant and equipment | 263 | 143 | ||||
| Purchase of property, plant and equipment | 10 | –3 285 | –1 663 | |||
| Proceeds from disposal of other non-current assets | 185 | 38 | ||||
| Purchase of other non-current assets | –251 | –364 | ||||
| Increase/(decrease) in recoverable taxes | – | –31 | ||||
| Interests received | 9 | 127 | 323 | |||
| Net cash flow investing activities | –3 011 | –1 707 | ||||
| Cash flow from financing activities | ||||||
| Transaction costs from capital increase | –673 | – | ||||
| Purchase of treasury shares | – | –9 | ||||
| Proceeds from borrowings | 19 | 5 246 | 1 542 | |||
| Repayment of borrowings | 19 | –258 | –2 586 | |||
| Interests paid | 19 | –538 | –884 | |||
| Interests paid on lease liabilities | 19 / 21 | –126 | –88 | |||
| Repayment of lease liabilities | 19 / 21 | –318 | –405 | |||
| Net cash flow financing activities | 3 333 | –2 430 | ||||
| Net increase/(decrease) in cash and cash equivalents | –231 | –1 472 | ||||
| Cash and cash equivalents, at the beginning of the year | 1 648 | 3 022 | ||||
| Increase/(decrease) in cash and cash equivalents | –231 | –1 472 | ||||
| Translation effect on cash | –76 | 98 | ||||
| Total Cash and cash equivalents, at the end of the year | 1 341 | 1 648 | ||||